BUN Creatinine Ratio: What It Actually Tells You — and Why Athletes Can Get Misleading Results
Table of Contents
Key Takeaways: BUN Creatinine Ratio
- A BUN creatinine ratio of around 10–20 is commonly considered normal, but a value above 20 does not by itself prove dehydration or a prerenal cause.
- The two components are often more informative than the ratio itself. BUN can rise with higher protein intake and other non-renal factors, while creatinine is influenced by muscle mass, recent exercise and creatine supplementation.
- In clinical practice, creatinine is far more commonly used than BUN or the BUN creatinine ratio. Urea or BUN usually becomes relevant when there is a specific question about kidney function, volume status or acute illness.
- Endurance exercise can change both urea and creatinine, but direct evidence on how the BUN creatinine ratio behaves after exercise is limited. A post-race change in the ratio therefore needs to be interpreted cautiously.
- Being an athlete is not, by itself, a reason to measure BUN or the BUN creatinine ratio, and the ratio has no clear role as a stand-alone tool for optimizing training or performance.
- The most useful approach is to look at BUN and creatinine separately, consider hydration, diet, muscle mass, supplements, recent training and symptoms, and use the ratio only as one piece of the overall clinical picture.
Introduction: BUN Creatinine Ratio
A flagged BUN creatinine ratio can be worrying, particularly because the usual explanation — “a high ratio means you are dehydrated” — sounds simple enough to act on. The reality is more complicated. The ratio’s traditional diagnostic use has performed poorly when tested in large patient groups [1][2], and both sides of the equation can be influenced by factors that are common in athletes, including protein intake, muscle mass, creatine use and recent training.
There is also an important practical distinction between the individual tests and the ratio itself. Creatinine is something I see constantly in clinical work because it is included in many routine blood panels and is commonly used when assessing kidney function. Urea — or BUN in laboratories that report blood urea nitrogen — comes up less often in my day-to-day general practice. In my experience, it becomes more relevant in hospital-based settings, such as emergency or inpatient care, where acute kidney injury or other acute illness is being evaluated. The BUN creatinine ratio is even less prominent in routine primary care and tends to appear more often in specific hospital or specialist contexts.
That matters because the ratio can look more definitive on a laboratory report than it really is. From a clinical perspective, I find it much more useful to first ask what is happening to BUN and creatinine separately, and then consider the circumstances around the test. In an athlete, diet, muscle mass, supplements and recent exercise may all affect that interpretation. The ratio can add context, but it is rarely meaningful as an isolated number.
What Is the BUN Creatinine Ratio?
The BUN creatinine ratio is blood urea nitrogen (BUN) divided by serum creatinine, both measured in mg/dL. A case report in the Indian Journal of Nephrology describes the normal ratio as usually falling between 10 and 20 [3], and 20 is the threshold typically used in reviews and textbooks to point toward a prerenal cause [1].
A note for Finnish and other European readers. Laboratories here usually report urea in mmol/L and creatinine in µmol/L, so the ratio looks completely different. Uchino and colleagues give the SI-unit equivalent of the classic cut-off: a BUN/creatinine ratio of 20 corresponds to 0.081 when urea (mmol/L) is divided by creatinine (µmol/L) [1]. Using that equivalence, you can convert an SI ratio to the familiar scale by multiplying by roughly 247 (20 ÷ 0.081). For example, urea 5.0 mmol/L and creatinine 80 µmol/L gives 0.0625, which corresponds to a BUN creatinine ratio of about 15.
Some papers put urea and creatinine on the same molar scale (both in mmol/L) before dividing, which gives numbers about 1,000 times larger than dividing urea in mmol/L by creatinine in µmol/L. On that scale, the conventional cut-off of 20 corresponds to roughly 81. Ratios of around 76–91 reported in some studies using this molar scale [2][4] are therefore not directly comparable with the familiar 10–20 scale — always check which units your lab report or a given paper is using.
From a practical clinical perspective, I think of creatinine and urea as answering somewhat different questions. Creatinine is commonly used as a general marker of kidney filtration, whereas urea can be more sensitive to factors that sit “upstream” of the kidney itself, including changes in renal perfusion. That distinction is useful, but it should not be taken too literally: neither marker is specific on its own.
This becomes particularly relevant in athletes. Creatinine can rise for reasons that have little to do with intrinsic kidney disease, including recent exercise, greater muscle mass and creatine supplementation. In my own practice, I see a fair number of patients who use creatine supplements, and that history can become important when interpreting an unexpected creatinine result.
In everyday general practice, however, I rarely need to add urea simply because creatinine has been measured. For many routine questions, creatinine provides the initial information I am looking for, while urea becomes more relevant when the broader clinical picture raises a specific reason to measure it. The same applies even more strongly to the BUN creatinine ratio: I find it more useful as a contextual clue than as a number to interpret in isolation.
Why the BUN Creatinine Ratio Was Used to Diagnose Dehydration — and Why the Evidence Is Weaker Than It Looks
The ratio is a conventional method for diagnosing dehydration [4]. The classic reasoning is that when kidney perfusion falls, antidiuretic hormone rises and the kidney reabsorbs more water and urea, so BUN rises more than creatinine [1]. On that basis, a ratio above 20 has been taught as a marker of “prerenal azotemia” — a reversible rise in urea and creatinine caused by reduced kidney perfusion rather than structural kidney damage [1].
When researchers actually tested this, the results were disappointing:
- The largest diagnostic study found no discriminating power. Manoeuvrier and colleagues analysed 1,103 adults admitted to the emergency department of Nantes University Hospital with creatinine above 133 µmol/L (mean age 75.7 years). Of these, 45% had prerenal and 55% had intrinsic kidney injury. The mean ratio did not differ between the groups (p = 0.758), and the area under the ROC curve was 0.5, meaning the ratio had no ability to tell the two apart. The authors describe their study as the largest to examine the ratio’s diagnostic performance [2].
- A high ratio did not behave like “benign” prerenal injury. In 20,126 patients admitted to a single Australian teaching hospital, 3,641 developed acute kidney injury, and just over half of those (53.2%) had a ratio above 20. Prerenal injury is expected to carry a lower mortality than structural injury, yet hospital mortality was higher in the high-ratio group (29.9% vs. 18.4%). The ratio’s distribution was also continuous rather than splitting into two groups, and the authors concluded that it cannot be used to separate prerenal injury from acute tubular necrosis [1].
- BUN, not creatinine, drove the difference. In the same study, BUN was 59% higher in the high-ratio group while creatinine was only 6% lower. The authors noted that BUN is influenced by several mechanisms — including parenteral nutrition, protein catabolism, steroid treatment and gastrointestinal bleeding — and described it as a marker of illness severity independent of kidney function [1].
- Newer data are somewhat less negative. A 2026 retrospective study of 590 hospitalized patients with acute kidney injury found that the urea-to-creatinine ratio was higher in prerenal than in parenchymal or post-renal kidney injury, despite substantial overlap between the groups. The authors described its stand-alone diagnostic performance as limited, but found that combining it with simple clinical variables improved discrimination, and supported its use as a complementary tool alongside a full clinical assessment [5].
- It may not even track hydration. A 2026 cross-sectional study sampled blood and urine from 921 fasting patients awaiting surgery at a hospital in China. The ratio did not correlate with four urine markers of dehydration, and patients classed as dehydrated by a urine-based index had essentially the same mean ratio as the others (77 vs. 76 on the study’s molar scale, p = 0.94). The authors concluded that the ratio may not reliably reflect hydration status and called for a repeat study in which the body volume deficit is known [4].
None of these studies were done in athletes. They do show, though, that a BUN creatinine ratio above 20 should not be read as proof of dehydration.
In practice, I do not usually rely on the BUN creatinine ratio to decide whether someone is dehydrated. In everyday clinical work, creatinine is much more readily available and is often interpreted together with the history, examination and the rest of the laboratory picture when volume depletion is a possibility. Hemoconcentration can sometimes provide additional context — for example, hemoglobin may rise when plasma volume contracts — but neither creatinine nor hemoglobin is a stand-alone hydration test.
I rarely find that urea needs to be added simply to answer the question of dehydration in routine general practice. It can become more relevant in emergency, inpatient or specialist settings, particularly when kidney function or a possible prerenal component is being assessed. Even there, I would regard urea and the BUN creatinine ratio as pieces of the overall picture rather than values that independently determine a diagnosis or a treatment decision.
What Raises BUN: Protein, Catabolism and Bleeding
Higher protein intake is one mechanism that can raise the BUN creatinine ratio by increasing BUN.
In a randomized crossover trial, 24 healthy young men followed a normal-protein diet (1.2 g/kg/day) and a high-protein diet (2.4 g/kg/day) for 7 days each. BUN was 19 mg/dL at the end of the high-protein week versus 14 mg/dL at the end of the normal-protein week, while serum creatinine was 1.1 mg/dL in both phases [6]. Calculated from those group means, the ratio moved from about 13 to about 17.
That pattern fits the wider evidence on creatinine. A 2026 meta-analysis of randomised trials in adults without chronic kidney disease found that high-protein diets did not significantly change serum creatinine (19 trials, 1,044 participants) [7]. Taken together with the trial above, higher protein intake appears to raise the numerator of the ratio while leaving the denominator largely unchanged.
BUN can also rise for reasons that matter more clinically. A retrospective study of 621 emergency patients with acute gastrointestinal bleeding found that a ratio of 35 had a specificity of 90.16% for an upper GI bleeding source, but its sensitivity was only 19.63%, so values below 35 did not rule an upper GI bleed out [8]. A 2026 meta-analysis of 17 studies reached a similar overall picture: above 30, pooled sensitivity was 38.8% and specificity 89.3%, and at the optimal cut-off of 22, sensitivity was 66.2%, specificity 71.0% and the area under the curve 0.740, which the authors described as moderate diagnostic accuracy [9]. For an athlete, a very high ratio combined with black stools, abdominal pain or unexplained anemia is not a “protein effect” to dismiss.
These mechanisms are useful for understanding what can move BUN, but in everyday clinical work they are often more interesting physiologically than decisive diagnostically. I rarely find much value in ordering urea or BUN as an isolated test without a specific clinical question behind it.
In my own practice, it becomes more relevant when kidney function is already under assessment — for example, when creatinine or another kidney-function marker is abnormal, or when an acute illness raises the possibility of a prerenal component. In that setting, urea can add context to the differential diagnosis, but it is still only one part of the overall picture.
That distinction matters when interpreting the studies above. High protein intake, gastrointestinal bleeding and other non-renal factors can all influence BUN, but the value itself does not usually point to a diagnosis in isolation. Clinically, I find it most useful when it helps explain why the kidney-related laboratory pattern looks the way it does, rather than as a stand-alone result that drives management.
What Raises Creatinine: Muscle Mass, Creatine and Muscle Damage
The denominator has its own athlete-specific quirks — and when creatinine rises for non-kidney reasons while BUN stays the same, the BUN creatinine ratio goes down.
Muscle mass. Baxmann and colleagues studied 170 healthy adults and found that serum creatinine correlated more strongly with lean mass than with body weight. Participants with moderate or intense physical activity had higher serum creatinine than sedentary participants (1.04 vs. 0.95 mg/dL), while cystatin C showed no significant correlation with lean mass and did not differ between the groups. The active group also reported higher protein intake than the sedentary group (1.4 vs. 1.1 g/kg/day), which illustrates that factors influencing BUN and creatinine can coexist. The authors suggested that cystatin C may be a more suitable way to assess kidney function in people with higher muscle mass when mild impairment is suspected [10].
Creatine supplementation. A 2026 meta-analysis of 26 randomized placebo-controlled trials (1,036 participants, including healthy individuals and people with chronic kidney disease) found that creatine supplementation increased serum creatinine by a mean 0.14 mg/dL. Creatinine-based estimates of glomerular filtration rate also fell, but GFR measured with Cr-EDTA did not differ significantly between the groups, and there were no significant differences in serum urea, albuminuria or proteinuria. The authors concluded that these findings likely reflect altered creatinine metabolism rather than kidney injury [11].
Muscle breakdown. In rhabdomyolysis, the massive release of creatinine from damaged muscle can push the ratio down [3]. In a published case report of rhabdomyolysis after a seizure, the BUN creatinine ratio stayed between 3.5 and 11.2 while the patient developed acute renal failure, and the author concluded that the ratio is not a reliable kidney marker in rhabdomyolysis [3]. This is a single seizure-associated case report, so it illustrates the mechanism rather than showing how often it happens in athletes.
There is another, much more ordinary situation I encounter in practice: a mildly elevated creatinine in an otherwise well patient who has come for fasting blood tests. Sometimes the person has simply had less fluid than usual before the sample, and relative volume depletion may contribute to the result. For an athletic or muscular patient, that can sit on top of the effects of muscle mass, recent exercise or creatine use.
This is something I often have to explain because an unexpected creatinine result understandably raises concern about kidney disease. From a clinical perspective, a small isolated increase does not tell me very much on its own. I would rather interpret it in the context of the patient’s previous results, hydration, muscle mass, recent training and supplement use than assume that a single mildly abnormal value represents impaired kidney function.
BUN Creatinine Ratio After Hard Training and Races
Endurance running can change both markers — and can therefore change the BUN creatinine ratio — and not always in the same proportion.
Marathon data. A 2025 systematic review and meta-analysis of nine marathon studies reported pooled serum creatinine of 0.88 mg/dL before the race, 1.38 mg/dL immediately after and 1.12 mg/dL at 24 hours. The authors note that heterogeneity for creatinine was substantial and that the available data did not allow formal testing of whether the pre–post changes were statistically significant [12]. The same review also gives estimated mean BUN creatinine ratios of 17.33 before the race, 15.33 immediately after and 19.33 at 24 hours [12], but these rest on much thinner evidence: the review lists the ratio as measured in only one of its included studies, a small cohort of 23 enrolled runners at the 2017 Hartford Marathon, whose median pre-race ratio was 17 [13]. (That the ratio estimates come from this single cohort is my reading of the review’s study table and methods, which convert medians to estimated means.) In a single study of 19 male non-elite marathon runners, serum creatinine rose from 0.96 to 1.28 mg/dL and urea from 35.2 to 43.2 mg/dL immediately after the race; by 48 hours urea was 35.2 mg/dL and creatinine 0.91 mg/dL. Despite the 48-hour creatinine value being statistically lower than the pre-race 0.96 mg/dL (p = 0.014), the authors described creatinine and urea as recovered by 48 hours [14].
Short run vs. ultramarathon. A study followed 16 amateur runners through a 100 km race (14 finished; two covered 51 km) and, separately, a 10 km run. In the paper’s relative-change analysis of blood uremic toxins, the largest rise after 10 km was in creatinine (1.26-fold), with no change reported in urea; after the 100 km event, urea showed the largest rise (1.76-fold) [15]. Elsewhere, the same paper reports statistically significant increases in urea after both races, so the 10 km urea result should be read with some caution [15]. The authors attributed the creatinine rise mainly to muscle injury and the urea rise to increased metabolism, probably with some reduction in kidney perfusion, and considered many creatinine-based “acute kidney injury” diagnoses after exercise overestimated. They also note that different lab methods were used after the two races, so the absolute values could not be compared directly [15].
Because these ratio figures describe essentially one small cohort and the review could not formally test the changes [12], they cannot show whether the same pattern holds in other cohorts or after other types of hard training. (This caution is my interpretation.)
Ultra-distance data. In an 80 km ultra-distance race, blood samples from 21 male runners showed plasma urea rising from 5.8 mmol/L at baseline to 9.2 mmol/L at the finish (a 59% increase). Serum creatinine rose from 90 µmol/L to a reported 136 µmol/L (a 52% increase), but the paper is internally inconsistent about the timing: the abstract gives 136 µmol/L as the 80 km value, while the results text states that serum creatinine peaked after 53 km. By day 9, none of the 21 runners with blood samples met creatinine-based criteria for acute kidney injury [16]. Because of the timing inconsistency, I have not calculated a ratio from these data.
One important point can get lost in all of these exercise studies: being an athlete is not, by itself, a reason to measure BUN or urea. In my clinical work, I use essentially the same indications as I would in anyone else — the test becomes relevant when there is a medical question about kidney function, volume status, acute illness or another specific differential diagnosis.
The fact that endurance exercise can alter urea, creatinine and their ratio is physiologically interesting, but that does not automatically make the measurement useful for sports performance. I do not see a meaningful role for the BUN creatinine ratio as a stand-alone tool for optimizing training or performance. For an athlete, its value is mainly clinical: helping interpret an abnormal laboratory pattern in the right context rather than providing a target to monitor or improve.
Conclusion: BUN Creatinine Ratio
The BUN creatinine ratio is easy to calculate and equally easy to over-interpret. Its traditional use above 20 as a marker of prerenal azotemia has performed poorly in large acute kidney injury cohorts: the ratio showed no ability to separate prerenal from intrinsic kidney injury in 1,103 emergency patients [2], while another large hospital study found higher rather than lower mortality among patients with acute kidney injury and a high ratio [1}. More recent evidence is somewhat less negative and suggests that the ratio may add information when combined with other clinical variables, but not as a stand-alone diagnostic test [5]. Likewise, in 921 fasting surgical patients, it did not correlate with urine markers of dehydration [4].
For me, the practical message is simpler than the physiology. I encounter serum creatinine constantly in routine clinical work, whereas urea or BUN is usually something I consider when there is a more specific question about kidney function, volume status or the differential diagnosis of acute illness. Even then, neither urea nor the BUN creatinine ratio makes the diagnosis by itself. Protein intake can raise BUN [6], while muscle mass and creatine supplementation can raise creatinine without necessarily indicating impaired filtration [10][11]. Recent endurance exercise can complicate the picture further, although direct evidence on the ratio itself after a marathon remains limited [12][13].
That is particularly important for athletes. Being an athlete is not, in my view, an indication to measure BUN or the BUN creatinine ratio, and I do not see the ratio as a useful stand-alone tool for optimizing training or performance. Its value is mainly clinical: helping make sense of an abnormal laboratory pattern when there is already a reason to investigate it. When creatinine looks unexpectedly high in a muscular athlete, factors such as hydration, recent training, muscle mass and supplement use may all matter, and in selected situations cystatin C can provide additional context.
The useful question is therefore rarely “Is the ratio high or low?” It is “Why do BUN and creatinine look the way they do in this person, at this time?” Read the two values separately, interpret them in the clinical context, and avoid turning the ratio into a diagnosis on its own. The BUN creatinine ratio can be a useful clue, but it is not the answer.
Bibliography
[1] https://doi.org/10.1093/ckj/sfs013
[2] https://doi.org/10.1186/s12882-017-0591-9
[3] https://doi.org/10.4103/0971-4065.45295
[4] https://doi.org/10.1080/00365513.2026.2713141
[5] https://doi.org/10.3390/jcm15176604
[6] https://doi.org/10.3945/ajcn.2009.27601
[7] https://doi.org/10.1111/dom.70996
[8] https://doi.org/10.22037/aaem.v7i1.400
[9] https://doi.org/10.1111/jgh.70224
[10] https://doi.org/10.2215/CJN.02870707
[11] https://doi.org/10.1007/s11255-026-05287-x
[12] https://doi.org/10.3390/medicina61101775
[13] https://doi.org/10.2215/CJN.01400219
[14] https://doi.org/10.3389/fphys.2020.00352
